nafamostat has been researched along with Thrombopenia in 9 studies
nafamostat: inhibitor of trypsin, plasmin, pancreatic kallikrein, plasma kallikrein & thrombin; strongly inhibits esterolytic activities of C1r & C1 esterase complement-mediated hemolysis; antineoplastic
| Excerpt | Relevance | Reference |
|---|---|---|
| "The pathology of coronavirus disease 2019 (COVID-19) is exacerbated by the progression of thrombosis, and disseminated intravascular coagulation (DIC), and cytokine storms." | 2.72 | COVID-19-associated coagulopathy and disseminated intravascular coagulation. ( Asakura, H; Ogawa, H, 2021) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (22.22) | 18.2507 |
| 2000's | 6 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Asakura, H | 1 |
| Ogawa, H | 1 |
| Saito, M | 1 |
| Gunji, Y | 1 |
| Kashii, Y | 1 |
| Odaka, J | 1 |
| Yamauchi, T | 1 |
| Kanai, N | 1 |
| Momoi, MY | 1 |
| Takahashi, H | 2 |
| Muto, S | 1 |
| Nakazawa, E | 1 |
| Yanagiba, S | 1 |
| Masunaga, Y | 1 |
| Miyata, Y | 1 |
| Tamba, K | 1 |
| Kusano, E | 1 |
| Matsuo, M | 2 |
| Matsuo, T | 4 |
| Asano, Y | 1 |
| Sawaki, D | 1 |
| Otani, Y | 1 |
| Kobayakawa, N | 1 |
| Sekita, G | 1 |
| Fukushima, K | 1 |
| Takeuchi, H | 1 |
| Ogawa, T | 1 |
| Takemura, T | 1 |
| Aoyagi, T | 1 |
| Wanaka, K | 1 |
| Moroi, K | 1 |
| Shiomi, Y | 1 |
| Kumano, H | 1 |
| Ishimura, N | 1 |
| Nishiwada, M | 1 |
| Ouga-Maruyama, S | 1 |
| Shibata, A | 1 |
2 reviews available for nafamostat and Thrombopenia
| Article | Year |
|---|---|
COVID-19-associated coagulopathy and disseminated intravascular coagulation.
Topics: Adult; Anticoagulants; Benzamidines; Blood Coagulation Disorders; Blood Coagulation Tests; COVID-19; | 2021 |
[Heparin-induced thrombocytopenia in patients on hemodialysis].
Topics: Anticoagulants; Arginine; Benzamidines; Guanidines; Heparin; Heparin, Low-Molecular-Weight; Humans; | 2004 |
7 other studies available for nafamostat and Thrombopenia
| Article | Year |
|---|---|
Refractory kaposiform hemangioendothelioma that expressed vascular endothelial growth factor receptor (VEGFR)-2 and VEGFR-3: a case report.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Combined Chemotherapy Protocols; Benzamidine | 2009 |
Combined treatment with nafamostat mesilate and aspirin prevents heparin-induced thrombocytopenia in a hemodialysis patient.
Topics: Adult; Anticoagulants; Aspirin; Benzamidines; Extracorporeal Circulation; Guanidines; Heparin; Human | 2003 |
A case of heparin-induced thrombocytopenia with sepsis and congestive heart failure--first autopsy report on Japan--.
Topics: Aged; Aged, 80 and over; Antibodies; Benzamidines; Enzyme-Linked Immunosorbent Assay; Fatal Outcome; | 2004 |
Management of uremic patients with heparin-induced thrombocytopenia requiring hemodialysis.
Topics: Aged; Aged, 80 and over; Anticoagulants; Arginine; Benzamidines; Female; Guanidines; Heparin; Humans | 2008 |
[Anesthesia for a patient with heparin-induced thrombocytopenia: a case report].
Topics: Aged; Anastomosis, Surgical; Anesthesia, Epidural; Anesthesia, Inhalation; Anticoagulants; Arterial | 1997 |
Can nafamostat mesilate be used for temporary management of hemodialysis in a patient with heparin-induced thrombocytopenia (HIT)?
Topics: Anticoagulants; Benzamidines; Guanidines; Heparin; Humans; Male; Middle Aged; Platelet Activation; P | 2001 |
[Bleeding tendency in chronic kidney failure with hemodialysis].
Topics: Benzamidines; Deamino Arginine Vasopressin; Estrogens; Factor VIII; Fibrinogen; Guanidines; Hemorrha | 1992 |